Oral anticoagulation in older adults with atrial fibrillation

被引:0
作者
Gosch M. [1 ]
机构
[1] Paracelsus Medizinische Privatuniversität Nürnberg,
[2] Universitätsklinik für Geriatrie,undefined
[3] Medizinische Klinik 2 — Schwerpunkt Geriatrie,undefined
[4] Klinikum Nürnberg,undefined
关键词
Atrial fibrillation; DOAK; Older adults; Oral anticoagulation;
D O I
10.1007/s15006-017-9597-2
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:68 / 75
页数:7
相关论文
共 37 条
[1]  
Camm A.J., Et al., 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Gui-delines for the management of atrial fibrilla-tion. Developed with the special contribution of the European Heart Rhythm Association, Eur Heart J, 33, pp. 2719-2747, (2012)
[2]  
Wilke T., Et al., Incidence and prevalence of at-rial fibrillation: An analysis based on 8.3 milli-on patients, Europace., 15, pp. 486-493, (2013)
[3]  
Dulli D.A., Stanko H., Levine R.L., Atrial fibrillati-on is associated with severe acute ischemic stroke, Neuroepidemiology., 22, pp. 118-123, (2003)
[4]  
Bonnemeier H., Et al., Presentation of atrial fibrillation and its management by cardiolo-gists in the ambulatory and hospital setting: MOVE cross-sectional study, Curr Med Res Opin., 27, pp. 995-1003, (2011)
[5]  
Kirchhof P., Et al., Management of atrial fibril-lation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: Primary results of the PRE-vention oF thromboemolic events--Euro-pean Registry in Atrial Fibrillation (PREFER in AF), Europace., 16, pp. 6-14, (2014)
[6]  
Kirchhof P., Et al., Management of patients with atrial fibrillation by primary-care physi-cians in Germany: 1-year results of the ATRI-UM registry, Clin Cardiol
[7]  
, 37, pp. 277-284, (2014)
[8]  
Denoel P., Et al., Could some geriatric charac-teristics hinder the prescription of antico-agulants in atrial fibrillation in the elderly?, J Aging Res, 2014, (2014)
[9]  
Deplanque D., Et al., Stroke prevention and at-rial fibrillation: Reasons leading to an inap-propriate management. Main results of the SAFE II study, Br J Clin Pharmacol., 57, pp. 798-806, (2004)
[10]  
Kirchhof P., Et al., 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, Eur Heart J, 37, pp. 2893-2962, (2016)